(Q37534560)

English

Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection.

scientific article published on July 2009

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19562644

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19562644%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

review article

1 reference

stated in

Europe PubMed Central

title

Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19562644

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19562644%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

main subject

respiratory syncytial virus

object named as

human respiratory syncytial virus

1 reference

based on heuristic

inferred from title

author name string

Jean-François Bonfanti

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19562644

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19562644%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

Dirk Roymans

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19562644

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19562644%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

publication date

1 July 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19562644

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19562644%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

published in

Current Opinion in Drug Discovery and Development

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19562644

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19562644%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

volume

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19562644

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19562644%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19562644

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19562644%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

page(s)

479-487

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19562644

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19562644%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

Identifiers

PubMed publication ID

19562644

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19562644

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19562644%20AND%20SRC:MED&resulttype=core&format=json

(Q37534560)

Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)